DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Information source: Allergan
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Ocular Hypertension

Intervention: brimonidine/timolol fixed combination (Drug)

Phase: Phase 2

Status: Completed

Sponsored by: Allergan


The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension

Clinical Details

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment

Primary outcome: IOP


Minimum age: 21 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Clinical diagnosis of glaucoma or ocular hypertension in both eyes

- Patient requires IOP-lowering in both eyes

Exclusion Criteria:

- Uncontrolled medical conditions

- Contraindication to beta-andrenoceptor antagonist or brimonidine therapy

Locations and Contacts

Artesia, California, United States
Additional Information

Starting date: July 1999
Last updated: May 27, 2011

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017